This study is looking at how well a medicine called axatilimab works compared to a placebo (a “fake” treatment) when used with corticosteroids to treat a condition called chronic graft-versus-host disease (cGVHD). cGVHD happens when donor cells attack the patient's body after a stem cell transplant. To join, you must be at least 12 years old and have new moderate or severe cGVHD needing treatment. You must not have had more than one stem cell transplant or have certain infections or diseases.
- Study Duration: The study involves various visits over a period, but it doesn't specify the exact length.
- Participation: Participants will receive either axatilimab or a placebo along with corticosteroids.
- Risks: There are risks like uncontrolled infections or other health issues that might exclude you from participating.
It's important to discuss with your doctor if this study might be right for you, considering the requirements and your health condition.
How understandable was the trial content above?
Hard to understand
Easy to understand